Literature DB >> 17316502

Immuno-parasitological assessment of bancroftian filariasis in a highly endemic area along the River Sabaki, in Malindi district, Kenya.

S M Njenga1, C N Wamae, C S Mwandawiro, D H Molyneux.   

Abstract

Lymphatic filariasis is endemic in the coastal areas of Kenya, with four major foci identified in the early 1970s. The prevalence and intensity of Wuchereria bancrofti infection, together with antifilarial antibody responses, were assessed in a historically highly endemic focus along the River Sabaki, in Malindi district. The prevalences of microfilaraemia and antigenaemia (detected by Og4C3 ELISA) were >20% and >40%, respectively, and both increased steadily with age. The high prevalences of antifilarial IgG1 (86%) and IgG4 (91%) responses indicate that most people living in this setting are exposed to W. bancrofti infection. The children investigated had higher levels of antifilarial IgG1 than the adults. The results of this study, based on a battery of currently available parasitological and immunological methods, provide an epidemiological update on lymphatic filariasis on the northern Kenyan coast. They show that the River Sabaki area is still an important focus for bancroftian filariasis and highlight the importance of implementing an elimination programme, to interrupt the transmission of W. bancrofti in all areas of endemicity in Kenya. The detailed baseline data collected in the River Sabaki area make the communities studied ideal as sentinel sites for epidemiological monitoring and the evaluation of the impact of mass drug administrations to eliminate lymphatic filariasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316502     DOI: 10.1179/136485907X156933

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  7 in total

1.  Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa.

Authors:  H Joseph; F Maiava; T Naseri; U Silva; P Lammie; W Melrose
Journal:  Ann Trop Med Parasitol       Date:  2011-12

2.  High prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemic.

Authors:  Patricia K Foo; Alessandro Tarozzi; Aprajit Mahajan; Joanne Yoong; Lakshmi Krishnan; Daniel Kopf; Brian G Blackburn
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-30       Impact factor: 2.184

3.  Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific.

Authors:  Hayley Joseph; Fuatai Maiava; Take Naseri; Fasihah Taleo; Malakai 'ake; Corinne Capuano; Wayne Melrose
Journal:  J Trop Med       Date:  2011-09-26

4.  Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control.

Authors:  Sammy M Njenga; Charles S Mwandawiro; C Njeri Wamae; Dunstan A Mukoko; Anisa A Omar; Masaaki Shimada; Moses J Bockarie; David H Molyneux
Journal:  Parasit Vectors       Date:  2011-05-25       Impact factor: 3.876

5.  A case study of risk factors for lymphatic filariasis in the Republic of Congo.

Authors:  Cédric B Chesnais; François Missamou; Sébastien D Pion; Jean Bopda; Frédéric Louya; Andrew C Majewski; Peter U Fischer; Gary J Weil; Michel Boussinesq
Journal:  Parasit Vectors       Date:  2014-07-01       Impact factor: 3.876

6.  Adult population as potential reservoir of NTD infections in rural villages of Kwale district, Coastal Kenya: implications for preventive chemotherapy interventions policy.

Authors:  Sammy M Njenga; Charles S Mwandawiro; Erastus Muniu; Mariam T Mwanje; Fatma M Haji; Moses J Bockarie
Journal:  Parasit Vectors       Date:  2011-09-14       Impact factor: 3.876

Review 7.  Spatial distribution of podoconiosis in relation to environmental factors in Ethiopia: a historical review.

Authors:  Kebede Deribe; Simon J Brooker; Rachel L Pullan; Asrat Hailu; Fikre Enquselassie; Richard Reithinger; Melanie Newport; Gail Davey
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.